Has Swathi Rao, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,421 in general payments to Swathi Rao, MD across 284 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Swathi Rao, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Swathi Rao, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Swathi Rao, MD

Endocrinology, Diabetes & Metabolism · Noblesville, INNPI 1871818419

Payments from drug & device makers

$6,421in general payments, 2019–2025

Across 284 payments — averaging $22.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abiomed$911
Abbott$824
Novo Nordisk$454
Amgen$291
Biotronik Inc.$264
Lilly USA, LLC$262
plus $3K from 50 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abiomed	24	$911
Abbott	23	$824
Novo Nordisk	25	$454
Amgen(2 entities)	15	$291
Biotronik Inc.	6	$264
Lilly USA, LLC	15	$262
Sanofi-aventis U.S. LLC	14	$261
Mannkind Corporation	10	$223
Corcept Therapeutics	10	$195
Boehringer Ingelheim	11	$183
AstraZeneca(2 entities)	10	$176
AbbVie(2 entities)	8	$170
Medtronic	7	$162
Novartis	6	$148
Amneal Pharmaceuticals LLC	7	$119
Tandem Diabetes Care, Inc.	5	$119
Insulet Corporation	6	$118
Dexcom, Inc.	5	$99
Bayer	5	$97
IBSA Pharma Inc.	5	$84
Xeris Pharmaceuticals, Inc.	4	$81
Neurocrine Biosciences, Inc.	3	$71
Teleflex LLC	2	$67
Recordati_rare_diseases_inc.	3	$67
BETA Bionics, Inc.	3	$65
Ultragenyx Pharmaceutical Inc.	3	$58
Johnson & Johnson	4	$57
Supernus Pharmaceuticals, Inc.	3	$47
Amarin Pharma, Inc.	3	$44
Amryt Pharma Holdings Ltd	2	$43
Merck	3	$41
Nalpropion Pharmaceuticals LLC	2	$39
Esperion Therapeutics, Inc.	2	$37
Radius Health, Inc.	2	$37
Pfizer	2	$35
Antares Pharma, Inc.	1	$30
Chiesi USA, Inc.	1	$30
Shire North American Group Inc	2	$30
Cequr Corporation	2	$30
Ascensia Diabetes Care US Inc.	1	$28
Lifescan, Inc.	2	$27
Currax Pharmaceuticals LLC	2	$27
Ascendis Pharma Endocrinology Inc	1	$26
Cardiva Medical, Inc.	1	$25
Kowa Pharmaceuticals America, Inc.	2	$23
Soleno Therapeutics, Inc.	1	$22
Averitas Pharma Inc.	1	$20
Companion Medical, Inc.	1	$20
Kyowa Kirin, Inc.	1	$20
EUSA Pharma (US) LLC	1	$19
Eisai Inc.	1	$19
Acerus Pharmaceuticals Corporation	1	$18
Sequel Med Tech, LLC	1	$16
Clarus Therapeutics Inc.	1	$15
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$13
Zealand Pharma US, Inc.	1	$12

How this compares

$6,421 in reported general payments places this provider in the 65th percentile of 134 endocrinology, diabetes & metabolism providers in Indiana.

See all endocrinology, diabetes & metabolism providers in Indiana →

Medicare billing

Part B allowed, 2024

$81,776

Medicare patients

226

Services billed

1,878

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Noblesville

Raj NagarajNoblesville$8K
Carmella Evans-MolinaIndianapolis$6.3M
Isaiah PittmanTerre Haute$1.5M
Ernest AsamoahIndianapolis$959K
Sana MeahMunster$829K
James MaloneIndianapolis$822K
Erica KretchmanRichmond$636K
Emily VeenemanSeymour$583K
Cary MariashIndianapolis$435K
Marian KirkmanIndianapolis$371K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →